Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/XSPRAY stock hub

STO/XSPRAY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/XSPRAYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

995.6M

Nasdaq Stockholm

Market data

Live price

Current market quote for this ticker.

Current price

STO/XSPRAY

In the news

Latest news · STO/XSPRAY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-28.6

P25 n/aP50 n/aP75 n/a

ROIC-13.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/XSPRAY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

158

Groups with data

Currency

SEK

Showing 158 of 158 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	26
Employees Change	2%
Employees Change Percent	8.33
Enterprise value	SEK 1B
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Isin	SE0009973563
Last refreshed	2026-05-10
Market cap	SEK 995.6M
Price	SEK 23.85
Price currency	SEK
Rev Per Employee	102,750x
Sector	Healthcare
Sic	2836
Symbol	sto/XSPRAY
Website	https://www.xspraypharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.52%
EV Earnings	-6.22x
P/B ratio	1.75x
P/S ratio	403.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	SEK 2.5M
Net Income	SEK -164.5M
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Pretax Margin	-6,674.98%
Profit Per Employee	SEK -6.9M
ROA	-12.75
Roa5y	-15.11
ROCE	-25.49
ROE	-28.62
Roe5y	-27.9
ROIC	-13.19

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-34.14%
Cagr3y	-19.08%
Cagr5y	-22.44%
EPS Growth Quarters	5
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0
Assets	SEK 736.4M
Cash	SEK 120.7M
Current Assets	SEK 149.9M
Current Liabilities	SEK 146.6M
Debt	SEK 147.9M
Debt Equity	SEK 0.26
Equity	SEK 569.4M
Interest Coverage	-8.68
Liabilities	SEK 167M
Long Term Assets	SEK 586.5M
Long Term Liabilities	SEK 20.4M
Net Cash	SEK -27.1M
Net Cash By Market Cap	SEK -2.73
Net Debt Equity	SEK 0.05
Tangible Book Value	SEK 569.4M
Tangible Book Value Per Share	SEK 13.64
WACC	4.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.02
Net Working Capital	SEK 10M
Quick ratio	0.84
Working Capital	SEK 3.3M
Working Capital Turnover	SEK 0.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-34.12%
200-day SMA	33.67
3Y total return	-47.02%
50-day SMA	26.37
50-day SMA vs 200-day SMA	50under200
5Y total return	-71.92%
All Time High	267
All Time High Change	-91.07%
All Time High Date	2020-08-06
All Time Low	23
All Time Low Change	3.7%
All Time Low Date	2025-04-07
ATR	1.73
Beta	-0.06
Beta1y	1.6
Beta2y	1.55
Ch YTD	-24.17
High	24.45
High52	64.1
High52 Date	2025-10-02
High52ch	-62.79%
Low	23.4
Low52	23.1
Low52 Date	2026-03-25
Low52ch	3.25%
Ma50ch	-9.57%
Price vs 200-day SMA	-29.17%
RSI	38.02
RSI Monthly	42.43
RSI Weekly	41.13
Sharpe ratio	0.14x
Sortino ratio	0.23
Total Return	-14.44%
Tr YTD	-22.02
Tr1m	-9.14%
Tr1w	-3.64%
Tr3m	5.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -150.3M
Operating margin	-6,095.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	28,244,128%
Net Borrowing	14,791,000
Shares Insiders	3.36%
Shares Institutions	36.38%
Shares Out	41,742,340
Shares Qo Q	0%
Shares Yo Y	14.44%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	97,036.55x
Bv Per Share	13.64
Ch1m	-9.14
Ch1w	-3.64
Ch1y	-37.07
Ch3m	2.8
Ch3y	-50
Ch5y	-73.5
Ch6m	-6.65
Change	2.14%
Change From Open	1.49
Close	23.35
Days Gap	0.64
Depreciation Amortization	2,563,000
Dollar Volume	2,696,671.8
Earnings Date	2026-05-06
EBIT	SEK -150.3M
EBITDA	SEK -147.8M
EPS	SEK -4.16
F Score	1
Financing CF	168,305,000
Fiscal Year End	December
Founded	2,003
Income Tax	SEK -91,000
Investing CF	-15,552,000
Is Primary Listing	1
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Ma150	28.44
Ma150ch	-16.14%
Ma20	26.83
Ma20ch	-11.11%
Net CF	-5,004,000
Next Earnings Date	2026-08-05
Open	23.5
Position In Range	42.86
Ppne	68,946,000
Price Date	2026-05-08
Ptbv Ratio	1.75
Relative Volume	1.19x
Revenue	2,466,000x
Tax By Revenue	-3.69x
Tr6m	-4.01%
Volume	113,068
Z Score	2.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/XSPRAY pay a dividend?

Capital-return profile for this ticker.

Performance

STO/XSPRAY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/XSPRAY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+36.4%

Share of float held by funds and institutions

Insider ownership

+3.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+14.4%

Negative means the company is buying back shares.

Technical

STO/XSPRAY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.0

Neutral momentum band

Price vs 200-day MA

-29.2%

50/200-day relationship not available

Beta (5Y)

-0.06

Less volatile than the market

Sharpe ratio

0.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/XSPRAY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/XSPRAY stock rating?

sto/XSPRAY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/XSPRAY analysis?

The full report lives at /stocks/sto/XSPRAY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/XSPRAY?

The latest report frames sto/XSPRAY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/XSPRAY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.